Wikidata

(Q39934931)

English

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma

scientific article published on January 2010

In more languages

Statements

title
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
author name string
Tim Eisen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
Uwe Trefzer
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
Anne Hamilton
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
Peter Hersey
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
Michael Millward
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
Jarl U Jungnelius
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
John Glaspy
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
publication date
1 January 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
page(s)
146-154
1 reference
stated in
Europe PubMed Central
PubMed ID
19862820
retrieved
15 September 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39934931&oldid=1879065894"